NA

ID: ALA3623782

Chembl Id: CHEMBL3623782

PubChem CID: 122192773

Max Phase: Preclinical

Molecular Formula: C60H98N22O19S2

Molecular Weight: 1495.71

Molecule Type: Protein

Associated Items:

Names and Identifiers

Canonical SMILES:  CC[C@H](C)[C@@H]1NC(=O)[C@@H]2CCCN2C(=O)[C@@H]2CCCN2C(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CO)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@@H]2CSSC[C@H](NC1=O)C(=O)N[C@@H](CC(N)=O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(N)=O)C(=O)NCC(=O)N[C@@H]([C@@H](C)O)C(=O)N2

Standard InChI:  InChI=1S/C60H98N22O19S2/c1-5-27(2)43-53(96)75-35-25-102-103-26-36(76-54(97)44(28(3)84)77-42(88)23-69-46(89)32(21-40(61)86)72-51(94)37-13-8-18-80(37)57(100)33(22-41(62)87)73-49(35)92)50(93)79-45(29(4)85)55(98)70-30(11-6-16-67-59(63)64)47(90)74-34(24-83)48(91)71-31(12-7-17-68-60(65)66)56(99)82-20-10-15-39(82)58(101)81-19-9-14-38(81)52(95)78-43/h27-39,43-45,83-85H,5-26H2,1-4H3,(H2,61,86)(H2,62,87)(H,69,89)(H,70,98)(H,71,91)(H,72,94)(H,73,92)(H,74,90)(H,75,96)(H,76,97)(H,77,88)(H,78,95)(H,79,93)(H4,63,64,67)(H4,65,66,68)/t27-,28+,29+,30-,31-,32-,33-,34-,35-,36-,37-,38-,39-,43-,44-,45-/m0/s1

Standard InChI Key:  UYYHWILULDLQBR-DNTFOILSSA-N

Alternative Forms

  1. Parent:

    ALA3623782

    ---

Associated Targets(Human)

F9 Tchem Coagulation factor IX (922 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
PLG Tclin Plasminogen (2339 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
KLK14 Tchem Kallikrein 14 (94 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
KLK4 Tchem Kallikrein 4 (51 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
PRSS1 Tclin Trypsin I (2306 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: ProteinTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 1495.71Molecular Weight (Monoisotopic): 1494.6820AlogP: #Rotatable Bonds:
Polar Surface Area: Molecular Species: HBA: HBD:
#RO5 Violations: HBA (Lipinski): HBD (Lipinski): #RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: CX LogP: CX LogD:
Aromatic Rings: Heavy Atoms: QED Weighted: Np Likeness Score:

References

1. de Veer SJ, Wang CK, Harris JM, Craik DJ, Swedberg JE..  (2015)  Improving the Selectivity of Engineered Protease Inhibitors: Optimizing the P2 Prime Residue Using a Versatile Cyclic Peptide Library.,  58  (20): [PMID:26393374] [10.1021/acs.jmedchem.5b01148]

Source